These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34617689)

  • 1. Transcriptional profiles of genes related to electrophysiological function in Scn5a
    Takla M; Edling CE; Zhang K; Saadeh K; Tse G; Salvage SC; Huang CL; Jeevaratnam K
    Physiol Rep; 2021 Oct; 9(19):e15043. PubMed ID: 34617689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
    Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
    Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannitol and hyponatremia regulate cardiac ventricular conduction in the context of sodium channel loss of function.
    Blair GA; Wu X; Bain C; Warren M; Hoeker GS; Poelzing S
    Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H724-H734. PubMed ID: 38214908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/- hearts.
    Zhang Y; Guzadhur L; Jeevaratnam K; Salvage SC; Matthews GD; Lammers WJ; Lei M; Huang CL; Fraser JA
    Acta Physiol (Oxf); 2014 Aug; 211(4):559-73. PubMed ID: 24913289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of Nedd4-2-binding capacity in PY-motif of Na
    Wang Y; Du Y; Luo L; Hu P; Yang G; Li T; Han X; Ma A; Wang T
    Acta Physiol (Oxf); 2020 Jun; 229(2):e13438. PubMed ID: 31900993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomics trajectory and molecular convergence of clinically relevant mutations in Brugada syndrome.
    Tambi R; Abdel Hameid R; Bankapur A; Nassir N; Begum G; Alsheikh-Ali A; Uddin M; Berdiev BK
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1935-H1948. PubMed ID: 33797273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking and localisation to the plasma membrane of Na
    Dulsat G; Palomeras S; Cortada E; Riuró H; Brugada R; Vergés M
    Biol Cell; 2017 Jul; 109(7):273-291. PubMed ID: 28597987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
    Stokoe KS; Balasubramaniam R; Goddard CA; Colledge WH; Grace AA; Huang CL
    J Physiol; 2007 May; 581(Pt 1):255-75. PubMed ID: 17303635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
    Wilde AAM; Amin AS
    JACC Clin Electrophysiol; 2018 May; 4(5):569-579. PubMed ID: 29798782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological characterization of a large set of novel variants in the SCN5A-gene: identification of novel LQTS3 and BrS mutations.
    Ortiz-Bonnin B; Rinné S; Moss R; Streit AK; Scharf M; Richter K; Stöber A; Pfeufer A; Seemann G; Kääb S; Beckmann BM; Decher N
    Pflugers Arch; 2016 Aug; 468(8):1375-87. PubMed ID: 27287068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number variations of SCN5A in Brugada syndrome.
    Sonoda K; Ohno S; Ozawa J; Hayano M; Hattori T; Kobori A; Yahata M; Aburadani I; Watanabe S; Matsumoto Y; Makiyama T; Horie M
    Heart Rhythm; 2018 Aug; 15(8):1179-1188. PubMed ID: 29574140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal interventricular differences in tissue architecture underlie right ventricular susceptibility to conduction abnormalities in a mouse model of Brugada syndrome.
    Kelly A; Salerno S; Connolly A; Bishop M; Charpentier F; Stølen T; Smith GL
    Cardiovasc Res; 2018 Apr; 114(5):724-736. PubMed ID: 29267949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCN5A-C683R exhibits combined gain-of-function and loss-of-function properties related to adrenaline-triggered ventricular arrhythmia.
    Steinberg C; Pilote S; Philippon F; Laksman ZW; Champagne J; Simard C; Krahn AD; Drolet B
    Exp Physiol; 2021 Mar; 106(3):683-699. PubMed ID: 33480457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Na(+) and higher K(+) channel expression and function contribute to right ventricular origin of arrhythmias in Scn5a+/- mice.
    Martin CA; Siedlecka U; Kemmerich K; Lawrence J; Cartledge J; Guzadhur L; Brice N; Grace AA; Schwiening C; Terracciano CM; Huang CL
    Open Biol; 2012 Jun; 2(6):120072. PubMed ID: 22773948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.
    Aiba T; Farinelli F; Kostecki G; Hesketh GG; Edwards D; Biswas S; Tung L; Tomaselli GF
    Circ Cardiovasc Genet; 2014 Jun; 7(3):249-56. PubMed ID: 24795344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.